Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Monoclonal Antibodies
    • 1.4.3 Personalized Cancer Vaccines
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
    • 1.5.2 Breast Cancer
    • 1.5.3 Lung Cancer
    • 1.5.4 Chronic Myeloid Leukaemia
    • 1.5.5 Bowel Cancer
    • 1.5.6 Other Cancer
  • 1.6 Coronavirus Disease 2019 (Covid-19): Personalized Cancer Medicine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Personalized Cancer Medicine Industry
      • 1.6.1.1 Personalized Cancer Medicine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Personalized Cancer Medicine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Personalized Cancer Medicine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Personalized Cancer Medicine Market Perspective (2015-2026)
  • 2.2 Personalized Cancer Medicine Growth Trends by Regions
    • 2.2.1 Personalized Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2015-2020)
    • 2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Personalized Cancer Medicine Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Personalized Cancer Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Personalized Cancer Medicine Players by Market Size
    • 3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2015-2020)
    • 3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Personalized Cancer Medicine Market Concentration Ratio
    • 3.2.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2019
  • 3.3 Personalized Cancer Medicine Key Players Head office and Area Served
  • 3.4 Key Players Personalized Cancer Medicine Product Solution and Service
  • 3.5 Date of Enter into Personalized Cancer Medicine Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2015-2020)
  • 4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2021-2026)

5 Personalized Cancer Medicine Breakdown Data by Application (2015-2026)

  • 5.1 Global Personalized Cancer Medicine Market Size by Application (2015-2020)
  • 5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Personalized Cancer Medicine Market Size (2015-2020)
  • 6.2 Personalized Cancer Medicine Key Players in North America (2019-2020)
  • 6.3 North America Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 6.4 North America Personalized Cancer Medicine Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Personalized Cancer Medicine Market Size (2015-2020)
  • 7.2 Personalized Cancer Medicine Key Players in Europe (2019-2020)
  • 7.3 Europe Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 7.4 Europe Personalized Cancer Medicine Market Size by Application (2015-2020)

8 China

  • 8.1 China Personalized Cancer Medicine Market Size (2015-2020)
  • 8.2 Personalized Cancer Medicine Key Players in China (2019-2020)
  • 8.3 China Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 8.4 China Personalized Cancer Medicine Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Personalized Cancer Medicine Market Size (2015-2020)
  • 9.2 Personalized Cancer Medicine Key Players in Japan (2019-2020)
  • 9.3 Japan Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 9.4 Japan Personalized Cancer Medicine Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Personalized Cancer Medicine Market Size (2015-2020)
  • 10.2 Personalized Cancer Medicine Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020)

11 India

  • 11.1 India Personalized Cancer Medicine Market Size (2015-2020)
  • 11.2 Personalized Cancer Medicine Key Players in India (2019-2020)
  • 11.3 India Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 11.4 India Personalized Cancer Medicine Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Personalized Cancer Medicine Market Size (2015-2020)
  • 12.2 Personalized Cancer Medicine Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020)
  • 12.4 Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview and Its Total Revenue
    • 13.1.3 Abbott Personalized Cancer Medicine Introduction
    • 13.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview and Its Total Revenue
    • 13.2.3 Merck Personalized Cancer Medicine Introduction
    • 13.2.4 Merck Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview and Its Total Revenue
    • 13.3.3 Novartis Personalized Cancer Medicine Introduction
    • 13.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Amgen
    • 13.4.1 Amgen Company Details
    • 13.4.2 Amgen Business Overview and Its Total Revenue
    • 13.4.3 Amgen Personalized Cancer Medicine Introduction
    • 13.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.4.5 Amgen Recent Development
  • 13.5 Celgene
    • 13.5.1 Celgene Company Details
    • 13.5.2 Celgene Business Overview and Its Total Revenue
    • 13.5.3 Celgene Personalized Cancer Medicine Introduction
    • 13.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.5.5 Celgene Recent Development
  • 13.6 Bayer
    • 13.6.1 Bayer Company Details
    • 13.6.2 Bayer Business Overview and Its Total Revenue
    • 13.6.3 Bayer Personalized Cancer Medicine Introduction
    • 13.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.6.5 Bayer Recent Development
  • 13.7 Roche
    • 13.7.1 Roche Company Details
    • 13.7.2 Roche Business Overview and Its Total Revenue
    • 13.7.3 Roche Personalized Cancer Medicine Introduction
    • 13.7.4 Roche Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.7.5 Roche Recent Development
  • 13.8 Astellas
    • 13.8.1 Astellas Company Details
    • 13.8.2 Astellas Business Overview and Its Total Revenue
    • 13.8.3 Astellas Personalized Cancer Medicine Introduction
    • 13.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.8.5 Astellas Recent Development
  • 13.9 Astrazeneca
    • 13.9.1 Astrazeneca Company Details
    • 13.9.2 Astrazeneca Business Overview and Its Total Revenue
    • 13.9.3 Astrazeneca Personalized Cancer Medicine Introduction
    • 13.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.9.5 Astrazeneca Recent Development
  • 13.10 Johnson & Johnson
    • 13.10.1 Johnson & Johnson Company Details
    • 13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
    • 13.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 13.10.5 Johnson & Johnson Recent Development
  • 13.11 Agilent
    • 10.11.1 Agilent Company Details
    • 10.11.2 Agilent Business Overview and Its Total Revenue
    • 10.11.3 Agilent Personalized Cancer Medicine Introduction
    • 10.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 10.11.5 Agilent Recent Development
  • 13.12 Takeda
    • 10.12.1 Takeda Company Details
    • 10.12.2 Takeda Business Overview and Its Total Revenue
    • 10.12.3 Takeda Personalized Cancer Medicine Introduction
    • 10.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2015-2020)
    • 10.12.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Abbott
    Merck
    Novartis
    Amgen
    Celgene
    Bayer
    Roche
    Astellas
    Astrazeneca
    Johnson & Johnson
    Agilent
    Takeda

    Market segment by Type, the product can be split into
    Monoclonal Antibodies
    Personalized Cancer Vaccines
    Other
    Market segment by Application, split into
    Breast Cancer
    Lung Cancer
    Chronic Myeloid Leukaemia
    Bowel Cancer
    Other Cancer

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players.
    To present the Personalized Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Personalized Cancer Medicine are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now